Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: no known allergies / adverse drug reactions attending: chief complaint: headache, fever major surgical or invasive procedure: lp on history of present illness: this is a 62yo m with nsclc stage iv s/p /taxol followed by maintenance bevacizumab as part of df-hcc 09-069, found to have brain mets and completed wbrt on , now presenting with severe and progressive headache and fever. his last chemo bevacizumab was in . states he has been having headaches since 2 months, are intermittent. now worse, waking up at night. pt also has dizziness associated with has. also endorses fever for 2 days. the pain is diffuse. it comes on gradually and lasts for several hours, then resolves entirely. endorses bluury vision and photophobia but denies neck pain. currently, pt is on a dexamethasone taper per his radonc and neuroonc recommendations. in the ed, his initial vs were: 101.2 100 132/85 16 96% ra. on physical exam, cnii- were intact, tongue deviates slightly to right. bue strength and sensation intact and symmetric, ble strength and sensation intact and symmetric. dysmetria on finger-nose-finger, r>l. labs notable for normal wbc, baseline hct and na of 127. cxr showed likely a superimposed acute interstitial process on the baseline severe emphysema, could be atypical infection such as viral or fungal etiologies though edema in the setting of emphysema may also present in this manner. ct head showed stable compared with priors, known mets remain ct occult, no acute process. lp was performed, csf showed protein 44, glucose 39, wbc 33 (poly 1, lymph 13, mono 8 eos 0, mesothe 6 and macroph 72), rbc 3. ua was neg. blood cultures and csf culture were submitted. lactate was 2.2. pt was given 2l ns, vancomycin, ctx and ampicillin for possible meningitis. pt was also given tylenol and 2 percocets for pain and fever. on transfer, vs were t 98.3 hr 75 o2 sat 94%on 2l nc bp 101/51. on arrival to the micu, pt states to be "fine" except for the persistent headaches. denies n/v currently. denies neck pain. no other complaints. ros: per hpi, otherwise neg except endorses chronic diffuse weakness and hand numbness. also endorses nausea/vomiting this am. endorses reflux symptoms. denies cp, dyspnea, abd pain. no cough, myalgias. admits to bloody stools during chemo but none since. no urinary complaints, diarrhea or constipation. past medical history: emphysema (per ct) pulmonary fibrosis (per ct) fev1/fvc 105% tobacco use motor vehicle collision requiring exploratory lap in low back pain, herniation of l4-l5 with compression of l5 nerve root osteopenia lung nodule, found hyperglycemia (hba1c 6.4 on ) past oncologic history: - nsclc stage iv non-squamous egfr wt - developed bilateral supraclavicular neck swelling and tenderness which he attributed to muscular strain - presented to pcp . for neck swelling - thyroid/neck us: normal thyroid gland, multiple bilateral enlarged lymph nodes measuring 2.2 x 1.6 x 2.2cm at the largest. - lymph node fna: negative for malignancy and just showed necrotic debris and macrophages. given the very high suspicion for malignancy, possibly lymphoma, he was subsequently referred for excisional lymph node biopsy. - left cervical lymph node excision that revealed a poorly differentiated carcinoma with osteoclast-like giant cells that was strongly immunoreactive for cytokeratin ae1/ae3/cam 5.2, cytokeratin 7 and ttf-1. it was not reactive for cytokeratin 20, s100 and mart 1. consistent with nsclc. - ct torso: showed substantial lymphadenopathy present in the chest, specifically a 2.5 x 1.5 cm right upper paratracheal node, a right mediastinal 9 x 14 mm node, a prevascular node measuring 2.1 x 1.2 as well as bilateral hilar and subcarinal adenopathy. he had a 1.6 x 1.2 cm right supraclavicular node as well as a left 1.5 cm x 9 mm supraclavicular node. within the lungs, there was irregular mass in the right upper lobe measuring 2.1 x 1.3 mm. bilateral severe emphysema, and bibasilar ground-glass opacities in the lower lobe described as fibrosis in the peripheral distribution. within the abdomen, the adrenals were unremarkable and in the pelvis there was no intraabdominal or pelvic lymphadenopathy. there is a t12 benign hemangioma, but no other bony disease. - bone scan: no evidence of osseous metastatic disease. - mri brain: no intracranial metastases - ct torso for trial baseline: unchanged from . - signed consent for df-hcc trial 09-069, b12 injection - started cycle 1 paclitaxel 200mg/m2 iv, carboplatin auc 6, bevacizumab 15mg/kg iv. this is arm b in the study. - c1d15 anc 420, grade 4 neutropenia - c2d1 paclitaxel 150mg/m2 iv, carboplatin auc 4.5, bevacizumab 15mg/kg iv (dose reduced per protocol) - ct scans with 32.7% decrease in target lesions, pr by recist. - c3d1 paclitaxel 150mg/m2 iv, carboplatin auc 4.5, bevacizumab 15mg/kg iv (dose reduced per protocol) - c4d1 09-069 paclitaxel 150mg/m2 iv, carboplatin auc 4.5, bevacizumab 15mg/kg iv (dose reduced per protocol) - staging scans with 37% decrease versus baseline - c5d1 bevacizumab (15mg/kg) maintenance - c6d1 bevacizumab (15mg/kg) maintenance - ct torso with ongoing pr by recist - c7d1 bevacizumab (15mg/kg) maintenance - c8d1 bevacizumab (15mg/kg) maintenance - ct torso with ongoing pr, 40% decrease from baseline - c9d1 bevacizumab (15mg/kg) maintenance - c10d1 bevacizumab (15mg/kg) maintenance, taken off trial due to travel plans, will remain under long term follow up for 09-069 for survival data. - ct (prelim) with stable disease - c11d1 bevacizumab (15mg/kg) maintenance - c12d1 bevacizumab (15mg/kg) maintenance - c13d1 bevacizumab (15mg/kg) maintenance - ct torso with slight interval increase in 2 known lesions, no new sites of disease - c14d1 bevacizumab (15mg/kg) maintenance - c15d1 bevacizumab (15mg/kg) maintenance - held c16 bevacizumab for new neurologic signs - mri showed new t1 hyperintense hyperenhancing lesions in the right basal ganglia and parietal lobes are concerning for metastatic disease. the parietal lobe lesions raised concern for leptomeningeal disease. - started whole brain xrt with 3000 cgy - completed whole brain xrt social history: lives with his ex-wife and daughter. originally he is from . he does smoke approximately ten cigarettes a day for the last 40 years. he does not drink alcohol now, but used to drink fairly heavily in the past. denies ivdu. family history: mother with . physical exam: vs- t 97.8 bp 116/68 hr 72 rr 18 o2 sat 96% on 2l weight 161 lbs height 69" gen- well-aapearing, nad heent- eomi, perrl, anicteric sclera, mmm, op clear neck- no nuchal rigidity cv- rrr, no murmurs resp- ctab, no wheezes or crackles abd- soft, nontender ext- no edema neuro- cnii-cnxii intact, strength and sensation intact throughout skin- no rashes pertinent results: labs: 09:20am blood wbc-8.5 rbc-4.64 hgb-14.7 hct-42.3 mcv-91 mch-31.6 mchc-34.7 rdw-14.8 plt ct-117* 09:20am blood neuts-83* bands-4 lymphs-9* monos-2 eos-1 baso-0 atyps-0 metas-0 myelos-1* 09:20am blood pt-12.0 ptt-24.7 inr(pt)-1.0 09:20am blood glucose-117* urean-23* creat-0.8 na-127* k-4.0 cl-89* hco3-26 angap-16 09:20am blood calcium-8.7 phos-2.4* mg-1.7 09:33am blood lactate-2.2* ua: neg micro: blood cultures: pnd csf culture: pnd imaging: ct head: impression: stable head ct examination demonstrating mild atrophy and chronic small vessel ischemic change. known brain metastases remain ct occult. cxr: impression: there is likely a superimposed acute interstitial process on the baseline severe emphysema. diagnostic considerations favor an atypical infection such as from viral or fungal etiologies in light of the clinical history provided. please note, edema in the setting of emphysema may also present in this manner. correlate clinically. brief hospital course: mr. was a 62 year-old man with nsclc stage iv with brain mets, completed wbrt , who presented with severe headache and fever on and transferred to the micu on due to worsening hypoxia and new b/l infiltrates. in the micu, the patient was treated with cefepim+vanco+azithro to cover hap and cap. also started on bactrim to cover pcp (chronic steroid use due to brain mets). the patient was ruled-out for tuberculosis. . over mr. micu stay he became increasingly more hypoxic and required 100% fio2 via facemask at all times. desaturations to the high 70s with small movements even with facemask in place. given hypoxia, fndings on imaging and an elevated bdg the working diagnosis was pcp . continued treatment with bactrim and completed course of vanc/cef/azithro for empiric coverage of hcap. . given the severity of the patient's infectious process and the poor prognosis of his malignancy; goals of care were adressed and the patient was made dnr/dni. despite treatment, his clinical status did not improve. patient expressed the wish to remain alive until his family could arrive from although did not want to be intubated. on , the patient's family arrived from . over the course of that day his respiratory status continued to deteriorate and he passed away quietly and peacefully on . medications on admission: 1. atenolol 25 mg tablet sig: one (1) tablet po once a day. 2. dexamethasone 2 mg tablet sig: two (2) tablet po twice a day. 3. lisinopril 10 mg tablet sig: one (1) tablet po daily (daily). 4. omeprazole 20 mg capsule, delayed release(e.c.) sig: one (1) capsule, delayed release(e.c.) po daily (daily). 5. prochlorperazine maleate 10 mg tablet sig: one (1) tablet po every six (6) hours as needed for nausea. 6. clindamycin phosphate 1 % solution sig: one (1) application topical at bedtime: apply to scalp nightly for rash at bedtime. 7. fluocinonide 0.05 % solution sig: one (1) application topical once a day: to scalp rash as needed. 8. ketoconazole 2 % shampoo sig: one (1) application topical once a day: apply to scalp daily in shower. 9. calcium carbonate-vitamin d3 600 mg(1,500mg) -400 unit tablet sig: one (1) tablet po twice a day: with food. 10. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day) as needed for constipation. 11. senna 8.6 mg tablet sig: 1-2 tablets po bid (2 times a day) as needed for constipation. 12. acyclovir 400 mg tablet sig: one (1) tablet po three times a day. 13. trazodone 50 mg tablet sig: one half tablet po at bedtime as needed for insomnia. discharge medications: n/a discharge disposition: expired discharge diagnosis: n/a discharge condition: n/a discharge instructions: n/a followup instructions: n/a md procedure: venous catheterization, not elsewhere classified spinal tap incision of lung diagnoses: unspecified essential hypertension long-term (current) use of steroids cardiac arrest secondary malignant neoplasm of brain and spinal cord pneumocystosis postinflammatory pulmonary fibrosis other emphysema malignant neoplasm of other parts of bronchus or lung hypoxemia do not resuscitate status disorder of bone and cartilage, unspecified 

Answer: The patient is high likely exposed to